Leukemia refers to cancer of the blood cells. It occurs due to changes in the bone marrow characterized with uncontrollable growth of the blood cells. According to Leukemia & Lymphoma Society, peripheral T-cell lymphomas (PTCLs) comprise a diverse group of uncommon and aggressive diseases, in which the patients have cancerous T-cells. Key types of lymphocytic and myeloid leukemia in adults are classified as chronic and acute respectively. T-cell leukemia is a sub-type of chronic lymphocytic leukemia (CLL). Chronic T-cell lymphocytic leukemia is further classified as large granular lymphocytic leukemia (LGLL), T-cell prolymphocytic leukemia (T-PLL), and adult T-cell leukemia/lymphoma (ATLL).
LGLL is more common in women than in men possessing slow growth of T-cell leukemia. The cause of LGLL is not known although around 25% of people diagnosed with LGLL are also known to have suffered from rheumatoid arthritis. T-PLL, which is a destructive sub-type of CLL, is more common in elderly men, though it may develop in women also. It can also affect the skin. Based on its various features, ATLL can be classified into acute, chronic, smoldering, and adult T-cell lymphoma. The cause of this type of cancer is a retrovirus called human T-cell leukemia virus (HTLV1). T-cell lymphocyte syndrome, known as Sezary syndrome, occurs in the skin. Usually, it shows sluggish growth with years to develop from mycosis fungoides present on the skin. Excessive night sweating, fatigue, weakness, unintentional weight loss, bone pain and tenderness, loss of appetite, fever, frequent infections, painless swollen lymph nodes, and red spots on the skin are a few symptoms of leukemia.
Most of the cancer types are staged into numbers to describe their extent in the body. This staging is based on the size and spread of the tumor. Unlike other types of cancer, leukemia is not staged. It is vital to understand in which organ (such as the liver, the lymph nodes, the spleen, the testicles, or the central nervous system) the leukemia cells have started accumulating. Out of all children diagnosed with ALL, around 205 children are identified with T-cell leukemia/lymphoma. This kind of cancer is more common in boys than girls. Also, it generally affects older children.
The global T-cells leukemia market can be segmented based on diagnosis, type of therapy, pipeline assessment, and geography. Blood tests and biopsy are major diagnostic procedures to confirm the presence of leukemia. Some of the drugs under investigation include mogamulizumab, lenaldekar, and alemtuzumab. For years, chemotherapy, surgery, and radiation therapy have been treatments for cancer. Targeted therapies such as imatinib and trastuzumab are primarily in use and they have emerged as standard cancer treatments. T-cell immunotherapy for leukemia involves removal of the patient’s own immune T-cells from the blood and their genetic modification or reprogramming in a laboratory. This modification or reprogramming allows potential targeting and killing of the patient’s own cancerous cells. Geographically, the global T-cells leukemia market can be categorized into four major regions viz. North America, Europe, Asia Pacific, and Rest of World.
Key players operating in the global T-cells leukemia market are Angimmune LLC, BioCryst Pharmaceuticals, Inc., Celgene Corporation, GlaxoSmithKline plc, Kyowa Hakko Kirin, Otsuka Holdings Co., Ltd., Mundipharma International Limited, and Novartis AG. Various institutes and government centers involved in the research on treatment for T-cells leukemia include National Institute of Cancer; Fred Hutchinson Cancer Research Center; University of Washington; Memorial Sloan Kettering Cancer Center; and National Heart, Lung, and Blood Institute.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.